Submit your paper to the European Heart Journal – Cardio-Oncology and extend the reach of your research across the cardiovascular community, contributing to advances in cardio-oncology and clinical ...
The ESC is inviting applications for the position of Editor-in-Chief of Cardiovascular Research (CVR). This is a unique opportunity to lead a globally recognised journal at the forefront of ...
Great science, direct to your inbox! Sign up for free to the My ESC News. This easy-to-read guide explains the 2025 ESC Clinical Practice Guidelines on myocarditis and pericarditis for patients, ...
ESC Clinical Practice Guidelines present the relevant evidence on a clinical issue to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic approach. The rapidly ...
Great science, direct to your inbox! Sign up for free to the My ESC News. The official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy – ...
Great science, direct to your inbox! Sign up for free to My ESC News.
Great science, direct to your inbox! Sign up for free to the My ESC News. Connect with our global community on LinkedIn to exchange ideas and stay up to date with the latest news and insights.
During this phase, the project team communicated with over twenty countries, resulting in nine countries participating in EuroHeart: Estonia, Hungary, Portugal, Romania, Denmark, Sweden, Lithuania, ...
Great science, direct to your inbox! Sign up for free to the My ESC News. The CESEE Study Group works to improve ACHD care, education, and collaboration in Central and Southeastern Europe through ...
Syncope is a common cause of cardiological consultation, accounting for 1-3% of all emergency department visits and up to 5% of hospital admissions in cardiology wards. Aetiology of syncope is ...
Cardiac amyloidosis is a progressive disease caused by the extracellular deposition of amyloid fibrils in the heart. More frequent than previously believed, it contributes to many common clinical ...
Dyslipidaemias represent a major modifiable risk factor for atherosclerotic cardiovascular disease, a leading cause of morbidity and mortality worldwide. This month’s FOCUS features resources centred ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results